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\s=b\We explored the possibility that neurologic and neuropsy-
chological changes constitute the earliest detectable manifesta-
tions of human immunodeficiency virus (HIV) infection. Without
knowledge of HIV status, we assessed neurologic signs and
symptoms and administered a battery of neuropsychological
tests to 208 homosexual men, of whom 84 were HIV negative, 49
were HIV positive and asymptomatic, 29 were mildly symptomat-
ic, and 46 had significant medical symptoms but not the acquired
immunodeficiency syndrome. There was no difference between
the HIV-negative and HIV-positive men in the frequency of neuro-
logic signs or of defective or borderline performance on any
neuropsychological test. However, HIV-positive men performed
slightly but significantly worse than HIV-negative men on tests of
verbal memory, executive function, and language. Similar results
were obtained when comparisons were limited to HIV-positive
medically asymptomatic and HIV-negative men. There was no
degradation of neurologic status or neuropsychological perfor-
mance across stages of HIV severity, but neurologic and neuro-
psychological summary scores correlated with CD4/CD8 ratios
in the HIV-positive group. Ratings of neurologic signs and symp-
toms correlated with neuropsychological summary scores in the
HIV-positive group only. Cognitive complaints were more fre-
quent in the HIV-positive men; they correlated with actual test
performance in the HIV-positive but not HIV-negative men. The
constellation of subjective and objective neuropsychological
and neurologic findings suggests the possibility of a definable
syndrome associated with HIV infection in asymptomatic
individuals.
{Arch Gen Psychiatry. 1991;48:131-138)
The present study explored the possibility that neurologicand neuropsychological changes constitute the earliest
detectable manifestations of human immunodeficiency virus(HIV) infection.
Even before immunologie changes or constitutional symp¬
toms emerge, HIV infection can be detected in the central
nervous system. For example, infection of the leptomeninges
occurs in seropositive subjects with and without neurologic
signs and symptoms.1"4 Also, in a study of 400 HIV-positive
Air Force personnel, 60% of the neurologically and immuno-
logically asymptomatic group had at least one abnormal cere-
brospinal fluid measure, suggesting that infection of the ner¬
vous system is common.6 These observations suggest that the
central nervous system may be a very early site of involve¬
ment in HIV infection.
Similarly, while dementia related to the acquired immuno¬
deficiency syndrome (AIDS) is recognized, the presence of
intellectual changes in HIV-positive individuals without
AIDS remains controversial. A number of studies have dem¬
onstrated significant differences between neuropsychological
performance in HIV-positive medically asymptomatic sub¬jects and HIV-negative controls,6-8 and others have noted a
continuum of neuropsychological change across medically
asymptomatic patients and those with lymphadenopathy syn¬
drome or AIDS-related complex (ARC).910 Several large
studies4,11,12 found no differences between HIV-positive, medi¬
cally asymptomatic and HIV-negative groups. In addition,
the relationship between neurologic and neuropsychological
changes has not been systematically evaluated; if such a
relation exists, it would strongly implicate central nervous
system involvement.
For the present study, homosexual men who were HIV
seropositive, as well as seronegative controls, underwent in-
depth neurologic and neuropsychological evaluations as part
of a multidisciplinary study.13,14 The evaluations were de¬
signed to investigate the presence of subtle neurologic and
cognitive changes in these men, possible interrelationships
between these changes, and the relationship ofneurologic and
neuropsychological changes to indexes of disease severity.
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Self-reports of cognitive and neurologic complaints were also




Two hundred eight homosexual or bisexual men volunteered and
gave informed consent. Inclusion and exclusion criteria, as well as
subject enlistment and screening procedures, are described in an
accompanying article.13 All subjects had to be able to follow instruc¬
tions and be tested in English.
Neurologic Evaluation
All neurologic evaluations were performed by neurologists. To
make the examination as blind to HIV status as possible, the exami¬
nation of neurologic signs was conducted before the elicitation of
symptoms and medical history. The neurologic evaluation required
45 minutes to complete.
Signs.—Full standardized neurologic evaluations were adminis¬
tered to all subjects. Each specific aspect of the examination was
coded separately so that the presence of individual signs could be
investigated. For example, extrapyramidal signs, believed to be
among the earliest signs of neurologic dysfunction in HIV,15 were
rated by means of selected parts of the Unified Parkinson's Disease
Rating Scale.16 Other aspects of the examination, such as motor
strength and reflexes, were rated by means of standard neurologic
terminology and measures. To evaluate cognitive function, a short 19-
item mental status screen was included.
Summary scores indicating an abnormality in five different catego¬
ries of neurologic signs were created: (1) alternating movements: any
impairment in finger tapping, pronation/supination of the hands,
opening/closing of the hands, or heel-toe tapping; (2) sensory abnor¬
mality: any increase, decrease, or distortion of pain, temperature,
tactile sense, position, or vibratory sense; (3) frontal release signs:
the presence of a glabellar, snout, suck, palmomental, or grasp reflex;(4) cranial nerve signs: any abnormality in the results of cranial nerve
examination; and (5) extrapyramidal signs: the presence of tremor,
rigidity, bradykinesia, sialorrhea, gait changes, hypomimia, hypo-
phonia, or postural instability.
Functional Categories.—The neurologist used the presence or
absence of specific neurologic signs to determine whether specific
functional systems mediated by the central and peripheral nervous
system were impaired. This involved interpreting the presence of
diverse signs as reflecting dysfunction in a single system. For exam¬
ple, pyramidal dysfunction might be associated with different neuro¬
logic signs, such as weakness, impaired rapid alternating move¬
ments, or increased tone. Guided by a modified version of the Kurtzke
Disability Status Scale for Multiple Sclerosis,17 the severity of impair¬
ment in nine categories of neurologic function was rated. Standard¬
ized conventions were developed for associating specific constella¬
tions of signs with particular functional categories and for rating the
severity of dysfunction. Ratings in each of the nine categories ranged
from 0 (not present) to 5 or 6 (maximal severity). The categories and
examples ofassociated signs are as follows: pyramidal (deficit in rapid
alternating movements, paraparesis or hemiparesis); cerebellar(ataxia [truncal or limb]); brain stem (nystagmus, extraocular weak¬
ness, dysarthria); sensory (vibratory loss, stocking-glove neuropa¬
thy); bowel and bladder (urgency, incontinence); visual (scotoma,
decreased visual acuity); cerebral (impairment on 19-item mental
status test); peripheral nerve (mild weakness, pain or sensory loss in
an asymmetric distribution, excluding stocking-glove neuropathy);
and extrapyramidal (rigidity, bradykinesia, tremor).
Three summary scores were derived from these functional catego¬
ries and their ratings: (1) functional score (the number of functional
categories, listed above, that yielded abnormal findings); (2) function¬
al severity (the sum of the scores in each functional category, used to
assess the overall severity of neurologic dysfunction); and (3) modi¬
fied Kurtzke score (ranging from 0 to 10, reflecting both the severity
and the number of defective categories). In a preliminary reliability
trial, two independent raters agreed on Kurtzke scores in 10 of 13
subjects; scores were one point apart in the remaining cases.
Symptoms.—Neurologic symptoms consisted of the patient's re¬
ported complaints as opposed to the objectively measured neurologic
signs. After the rating of signs was complete, subjective complaints
were elicited. Subjects were asked about their self-perceived func¬
tioning in a structured format (R. Price, unpublished). This interview
rated the presence of 11 symptoms grouped into three broad symp¬
tom areas: cognitive, motor/coordination, and behavior/mood. Cogni¬
tive symptoms included the following: concentration/speed of
thought (diminished concentration; mental slowing); reading/televi¬
sion (increased effort required); memory (more forgetful than usual;
may miss appointments); and speech (word-finding difficulty). Motor/
coordination symptoms included the following: gait (unsteadiness,
imbalance, or slowness); dexterity (slowing or clumsiness of hands);
involuntary movements (tremor or other adventitious movements);
and bladder incontinence (hesitancy, urgency, or incontinence). Be¬
havior/mood symptoms included the following: mood (depression,
interference with function, requiring medication or therapy);
apathy/withdrawal (diminished interest in social activities); and emo¬
tional lability (easily agitated, may affect interactions).
For each symptom, the examiner read to the subject a series of
choices ranging from denial of the symptom through four descriptions
of progressively more severe symptomatic complaints; the subject
was asked to choose the response that was appropriate for him at the
time of the visit. This provided a rating for each symptom ranging
from 0, representing normal function, to 4, very severe dysfunction.
Additional summary scores included indexes of the presence or ab¬
sence of symptoms in the three general areas assessed and a final
measure summarizing the presence or absence of any subjective
complaint. (A copy of this interview is available on request.)
Neuropsychological Examination
The neuropsychological examination, performed without knowl¬
edge of HIV status, lasted approximately 2 hours. There were sever¬
al considerations taken in selecting the test battery. First, prelimi¬
nary reports of studies in seropositive asymptomatic subjects and
patients with ARC indicated deficits in visuomotor abilities and
attention.5 Similarly, these areas are reportedly affected in AIDS-
related dementia.18 The present battery was designed to characterize
these deficits more effectively. Our test selection was also guided by
our experience in assessing cognitive deficit in other diseases where
the initial manifestations are quite subtle. For example, since there
are suggestions that HIV might affect the basal ganglia and other
subcortical structures, we selected tests that in our experience were
sensitive to the cognitive functions associated with these areas.19
However, since relatively little is known about early AIDS-related
changes, the battery was also designed to assess a wide range of
abilities to search for patterns of strengths and weaknesses that
might not have been apparent from the early studies. Finally, since
the present cohort was to be followed up longitudinally, some tests
were included that might be more useful for assessing changes in
mentation associated with dementia than for any possible early
changes in cognition.
Tests used are described below, loosely organized by the cognitive
functions they were intended to assess.
A modified version of the Mini-Mental State Examination was
administered as a brief mental status screening test.20,21 Included in
the modified Mini-Mental State Examination is the Wechsler Adult
Intelligence Scale digit span subtest,22 which was scored separately
and included with the tests of attention described below. General
intelligence and visuospatial reasoning were assessed with a 24-item
version of Raven's Progressive Matrices.23 To assess abstract reason¬
ing, the first half of the Conceptual Levels Analogies Test, consisting
of21 verbal analogies, was administered.24
Two tests were used to assess memory. The first was a 12-item, six-
trial selective reminding test that assessed verbal memory.25 Fifteen
minutes later, the subject's delayed recall for the word list was
assessed and words not recalled were administered in multiple-choice
arrays to assess delayed recognition. The second test, the Benton
Visual Retention Test, assessed nonverbal memory.26 Delayed recog¬
nition was assessed 15 minutes later with multiple-choice arrays.
A series of tests assessed different aspects of language ability.
Naming was assessed with the Boston Naming Test,27 abbreviated by
administering every other item for a total of 30 pictures to be named.
Verbal fluency was assessed with the Controlled Oral Word Associa¬
tion Test (60 seconds for each of the letters C, F, and L)28 and the
Animal Naming Test.29 The sentence repetition subtest of the Boston
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Diagnostic Aphasia Examination assessed repetition of high- and
low-probability phrases.29
The Stroop Color-Word Test30 and the Odd Man Out Test31 were
used to assess executive or "frontal lobe" function. The final section of
the Stroop Color-Word Test requires the subject to attend selectively
to one oftwo competing stimuli. The Odd Man Out Test is a test ofthe
ability to switch set. The subject is asked to use a consistent selection
rule to determine which of three symbols on a card does not belong
with the other two. The subject must then systematically alternate
between two selection rules over four trials, each consisting of 10
cards. The Trail Making Test was also administered as a screening
test, test of speeded performance and, in part B, a test of rapid
sequencing and set shifting.32
Visuospatial function was assessed with Wechsler Adult Intelli¬
gence Scale-Revised Block Design,33 the Benton Line OrientationTest,34 and the Benton Visual Retention Test (form C, copy).26
To assess attention, two types of cancellation tasks, one using a
shape and another a letter triad as targets,35 and the Wechsler AdultIntelligence Scale-Revised digit symbol subtest33 were adminis¬
tered. A 20-trial choice reaction time task was also administered. In
this task, two simple shapes appear on the computer screen simulta¬
neously and without a preceding warning signal. The subject re¬
sponds with a differential button-press indicating whether the de¬
signs are the same or different. Reported data are for performance
after a 20-trial practice block.
Motor speed and praxis were assessed with the Perdue Pegboard.36
Two trials for dominant and nondominant hands as well as both hands
together were administered.
In addition to comparing raw scores across groups of interest,
neuropsychological test performance was evaluated in two ways:
summary scores were constructed on the basis of evaluation of sub¬jects' performance in comparison with normative populations, and
experienced clinicians evaluated overall performance on the exami¬
nation and derived a clinical impression. These are described below.
Comparisons With Normative Populations.—Performance on
each test was compared with that expected on the basis of extant
norms derived from populations of the the same age and education
and then rated as normal, borderline (at least 1 SD below the mean),
or defective (at least 2 SDs below the mean). One set of summary
scores was the number of areas, as described above, in which a
subject produced borderline or defective performance.
A global performance rating (GPR) was derived to summarize
overall neuropsychological performance with reference to normative
data and to rank performance along a continuum of severity. Criteria
are summarized in Table 1.
Clinical Impression.—Although it is informative to compare
groups' performance on individual neuropsychological tests or to
contrast norm-based summary measures, clinical neuropsychological
evaluation typically is based on interpretation of a full battery of tests
by a trained clinician. Often, there are patterns of performance or
areas of interrelated performance that can be appreciated and inter¬
preted by the clinician but are not amenable to statistical summary
measures. The clinical impression variable was created to evaluate
subjects' neuropsychological performance in this manner. Based on
the independent judgment of two experienced neuropsychologists
who were blind to HIV status, a clinical impression ofneuropsycholo¬
gical performance—normal, borderline, or abnormal—was generat¬
ed. While the clinician had access to the test scores and norms, the
impression was not based purely on the presence or number of
borderline or defective scores, but on the clinician's overall impres¬
sion of the subject's performance. The raters had not administered
the tests, but the testers were available to describe any factors
particular to any individual's testing session that might influence
performance. Disagreements between raters occurred in 12% of
cases. These were discussed and a consensus was reached for every
case.
Other Evaluations
As described in an accompanying article,14 subjects underwent a
structured psychiatric interview to determine if they met DSM-III-R
criteria for past or present major depression, drug abuse, or other
psychiatric diagnoses. Other psychiatric rating scales, including the
Hamilton Depression Scale and Hamilton Anxiety Scale, were
administered.
Table 1 .—Definition and Distribution of Global Ratings in
HIV-Negative and HIV-Positive Groups*
HIV HIV
Global Performance Rating Negative Positive
0. No performance deficit 40 (47.6) 52 (41.9)
1. Borderline performance (-2<z:£ -1 )
in 2 or more areast 3 (3.6) 20 (16.1)
2. Defective performance (z< -2) in 1
areaf 32 (38.1) 34 (27.4)
3. Defective performance in 2 or more
areast 7 (8.3) 17 (13.7)
4. Defective performance in memory and
in 2 or more other areast 2 (2.4) 1 (0.8)
*HIV indicates human immunodeficiency virus. Numbers in parentheses are
within-group percentages represented by each frequency.
tBased on age- and education-appropriate norms.
RESULTS
Demographics
As described in more detail in an accompanying article,13 the cohort
was composed of 124 HIV-positive men and 84 HIV-negative men. Of
the HIV-positive subjects, 49 were completely asymptomatic, 29 had
mild medical symptoms such as lymphadenopathy, and 46 had signifi¬
cant medical symptoms consistent with ARC but did not meet criteria
for AIDS.
Age ranged from 18 to 60 years. The HIV-positive and HIV-
negative men were comparable in age, education, and handedness(Table 2). As described in detail in an accompanying article,13 the
groups were also comparable with regard to the frequency of psychi¬
atric diagnosis, rated depression and anxiety, and global functioning.
Although all men were tested in English, 18 men reported that
English was not their first language. The distribution of these men
across disease stage was not equal: two were HIV negative, 12 were
HIV positive and asymptomatic, two had mild medical symptoms,
and two had significant medical symptoms consistent with ARC.
Hollingshead socioeconomic status was also not equally distributed;
mean socioeconomic status in the HIV-positive men was 49.2 ± 12.4
as compared with 53.1 ± 9.3 in the HIV-negative men (t = 2.61; P<. 1).
Comparisons of HIV + and HIV- Men
Summary Measures.—There was no difference between HIV-
positive and HIV-negative subjects on any of the summary measures
for neurologic signs, including functional ratings and Kurtzke scores(Table 2).
In the entire study cohort, neurologic summary variables correlat¬
ed with age and with Hamilton Anxiety Scale and Hamilton Depres¬
sion Scale scores (Table 3). In each case, there was a tendency for
increased severity of neurologic signs to be associated with higher
age or increased depression or anxiety. These relationships were also
seen when correlations were calculated separately for HIV-negative
and HIV-positive men (Table 3).
On the neuropsychological evaluation, there was no difference
between the HIV-positive and HIV-negative men in mean GPR
scores. However, there was a significant difference in the distribu¬
tion of GPR scores ( 2 = 11.4; P<.05). Based on inspection of stan¬
dardized residuals in each cell, this difference was due primarily to a
higher frequency of HIV-positive men with a GPR of 1, that is,
borderline performance on tests of at least two cognitive areas (Table
1).
There was a small but significant correlation of the GPR and
education, such that subjects with higher levels of education tended
to have lower ratings (Table 3). Education did not correlate with the
neuropsychologist's impression, however.
In the entire study cohort, both the GPR and the neuropsycholo¬
gist's impression correlated with the assessments of anxiety and
depression. In each case, increased anxiety or depression was related
to poorer performance on the neuropsychological battery (Table 3).
However, when these correlations were calculated separately for
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 84 49 75
Handedness, % R/L/both 87/13/0 76/20/4 84/15/1
Age, y 37.7 ±8.9 39.7±8.1 37.5 ±8.2
Education, y 16.5 + 2.1 16.2±2.6 15.7 ±2.4
Socioeconomic status 53.1 ±9.3 50.2 ±12.1 48.5 ±12.7
CD4/CD8 ratio 1.7 ±0.6 0.7 ±0.4 0.5±0.3
CD4 cell count, x109/L 0.833 ±0.267 0.388 ±0.216 0.411 ±0.232
CD8 cell count, x10»/L 0.539 ±0.203 0.656 ±0.256 0.946 ±0.544
Neurologic findings
Kurtzke scale 1.2 ±0.7 1.1 ±0.7 1.1 ±0.7
Functional scale 1.4±1.1 1.4±1.0 1.3±1.1
Functional severity 1.8±1.5 1.7±1.3 1.6±1.5
Neuropsychological findings
Global Performance Rating 1.1 ±1.2 1.3 + 1.1 1.1 ±1.2
Neuropsychologist's impression 0.4 ±0.7 0.5 ±0.7 0.5 ±0.7
*HIV indicates human immunodeficiency virus.








Age .216t .173t .107 .012
Education .031 .048 .143t -143 
Hamilton Anxiety Scale 285t 308t 160 .146 
Hamilton Depression Scale .229t .223t .145t .144t
HIV-negative men
Age .092 .025 .205t .111
Education .070 .035
.274t -.246t
Hamilton Anxiety Scale .434t .392t .122 .065
Hamilton Depression Scale .299t .278t -.035 .053
HIV-positive men
Age .312t ,294t -.033 .059
Education .003 .050 -.071 .083
Hamilton Anxiety Scale 187 257t 168t .187 
Hamilton Depression Scale 206t 207t 232t .2411
*HIV indicates human immunodeficiency virus; GPR, Global Performance Rating. Values given are Pearson's product-moment correlations.
tP<01.
+P<.05.
HIV-negative and HIV-positive men, a different pattern was seen:
the neuropsychological summary variables correlated with the Ham¬
ilton Depression Scale and the Hamilton Anxiety Scale only in the
HIV-positive men. This suggests that depression and anxiety may
have played a greater role in the neuropsychological performance of
the HIV-positive then the HIV-negative men. In contrast, education
correlated with neuropsychological summary scores in the HIV-
negative men only.
Although the present study used extant norms for the neuropsy¬
chological tests administered to determine the rate of defective per¬
formance, other studies have derived norms from the study popula¬
tion itself.4,12 One summary measure that has been used in this regard
is the mean deviation from average performance on each test, ex¬
pressed in terms of SDs from the group mean performance. To
address this issue, the mean and SD of all (both HIV-negative and
HIV-positive) subjects' scores on each neuropsychological test were
calculated. Each subject's score on every test was then expressed in
terms of« scores, and the mean ofall  scores for each subject was then
calculated. There was a small but significant difference between the
mean
 score in the HIV-negative and HIV-positive groups (mean  
score = 0.072 and
-0.051, respectively; P<.01). This difference re¬
mained significant when only asymptomatic HIV-positive men were
contrasted with the HIV-negative group.
Individual Scores.—The frequency of individual neurologic signs
did not differ between HIV-positive and HIV-negative subjects. In
the HIV-negative and HIV-positive subjects, respectively, the fol¬
lowing were the percentages of men with specific neurologic signs:
difficulties with alternating movements, 3.6% and 7.3%; sensory
abnormalities, 53.6% and 43.5%; frontal release signs, 27.4% and
31.3%; cranial nerve signs, 25.0% and 25.0%; and extrapyramidal
signs, 17.9% and 18.5%.
All test scores were included in an omnibus multivariate analysis of
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CLAT 2.89 .05 12.25 .001 1.56 NS
Selective Reminding Test
Total recall 3.11 .05 0.31 NS 1.58 NS
Long-term storage 3.02 .05 0.15 NS 1.49 NS
Long-term retrieval 2.63 .052 0.08 NS 1.43 NS
Boston Naming Test 4.28 .01 66.65 .001 9.30 .001
Controlled Word Association 2.98 .03 0.76 NS 5.49 .001
Sentence Repetition
High probability 1.52 NS 7.35 .01 3.34 .021
Low probability 2.53 NS 15.37 .001 6.72 .001
Odd Man Out
Trial 1 2.87 .05 2.91 NS 2.63 NS
Trial 2 2.95 .05 8.47 .01 4.84 .01
Digit Symbol (age scaled) 2.94 .05 0.46 NS 2.73 .05
Cancellations
Letter triad 0.64 NS 1.26 NS 3.30 .05
Shape 0.57 NS 0.97 NS 2.73 .05
Backwards Digit Span 3.34 .05 0.01 NS 2.98 .05
*MANOVA indicates multivariate analysis of variance; CLAT, Conceptual Levels Analogies Test; and NS, not significant. Only variables with significant stage(human immunodeficiency virus [HIV] negative, asymptomatic HIV positive, mildly symptomatic HIV positive, and acquired immunodeficiency syndrome-related
complex), language (first language English vs other), or stage  language interactions are listed.
variance (MANOVA) comparing the performance of the men at four
stages ofHIV infection: seronegative, seropositive and asymptomat¬
ic, mildly symptomatic, and ARC. To control for possible confounding
effects, the following variables were included as factors in the
MANOVA as well: first language (English vs other), history of
learning disability, history of psychiatric disorder or substance
abuse, and current psychiatric disorder or substance abuse. Also
included were appropriate interactions of these factors. Socioeco¬
nomic status ratings and Hamilton Depression Scale and Hamilton
Anxiety Scale scores were included as covariates. Significant effects
included HIV stage (Hotelling Ie = 2.05, P<.011), language (Hotell-
ing 7* = 1.8, P<.01), and the stage  language interaction (Hotelling7*=2.32, P<.01). None of the other potential contributing variables
approached significance.
The univariate F tests from the omnibus MANOVA for which there
was a significant stage or stage  language effect were examined.
These are summarized in Table 4. For many of the tests in which there
was a significant stage effect, there was also a significant stage  lan¬
guage interaction, implicating the role of fluency in English in the
relationship between HIV stage and performance. However, this
was not the case for the several measures from the selective remind¬
ing test, as well as for the initial trial of the Odd Man Out Test, where
only the stage effect was significant. For the Conceptual Levels
Analogies Test, there were significant stage and language effects,
but no significant interaction.
Post hoc analyses were calculated from the omnibus MANOVA to
determine which of the four HIV stages accounted for the significant
stage effect. In simple contrast analyses, the HIV-negative and HIV-
positive men differed significantly (Hotelling 7* = 0.86, P<.01).
Although the MANOVA protected against type I error, its power
to detect potential significant effects was reduced because ofthe large
number of dependent variables included, as well as possible failure of
the distribution of several neuropsychological test score results to
meet assumptions underlying the MANOVA. In addition, the pres¬
ence of a missing value on any variable is sufficient to eliminate a
subject from the MANOVA. Since an issue ofspecific interest was the
potential performance difference between HIV-negative and HIV-
positive asymptomatic men, a series of exploratory univariate re¬
gression analyses were calculated to compare these two groups'
performance on the neuropsychological test battery. Based on the










Functional severity .0 .079
-
.242t
Kurtzke scale .024 .096 -.105
Neuropsychological findings
Global performance rating .004 .194 -.206 
Neuropsychologist's impression -.005 .184 -.147
*HIV indicates human immunodeficiency virus.
tP<.01.
$P<.05.
results of the omnibus MANOVA, all the univariate regression ana¬
lyses controlled for language. The following variables differed signifi¬
cantly in the two groups: digit span forward (t = -2.28, P<.05);
selective reminding test total recall (i = -2.35, P<.05), long-term
retrieval « =
-2.61, P<.01), long-term storage (i = -2.69, P<.01),
consistent retrieval (t=
-2.40, P<.05), and delayed recall(t=
-2.08, P<.05); Controlled Oral Word Association Test(t=
-
2.21, P<.05); and Odd Man Out Test (t= -2.05, P<. 05). Along
with and independent of the significant serologie status effect, the
effects of first language were apparent for many variables.
Relationship of Performance to Severity of HIV Infection
An inverse correlation between the neurologic summary variables
and CD4/CD8 cell ratio was seen in the HIV-positive group but not in
the HIV-negative group. As the CD4/CD8 cell ratio decreased, the
neurologic summary indexes increased, implying an increased num¬
ber of defective areas or increasing severity of neurologic disease(Table 5). Similarly, the CD4/CD8 ratio correlated with the GPR only
in the HIV-positive group (Table 5).
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Functional score .194t 215t
Functional severity ,142t
Kurtzke scale .113 076
148t
HIV-negative men
Functional score .127 066
Functional severity .115 014
Kurtzke scale .076 083
HIV-positive men




Kurtzke scale .139 185t





To investigate the possible relationship between subtle neurologic
and neuropsychological changes, correlations between summary
variables in the two domains were calculated. Significant correlations
were seen between summary variables of the neurologic and the
neuropsychological examinations in the entire cohort. However,
when the cohort was stratified into HIV-positive and HIV-negative
groups, significant correlations were seen only in the HIV-positive
group, suggesting that this relationship is particular to the HIV-
positive men (Table 6). In addition, in all cases the coefficients of the
correlation between neurologic and neuropsychological summary
measures were significantly higher in the HIV-positive than the
HIV-negative group (P<.05).
Since neurologic summary measures correlated with scores on the
Hamilton Depression Scale and the Hamilton Anxiety Scale in both
HIV-positive and HIV-negative groups, while neuropsychological
measures correlated with these scales in the HIV-positive group
only, the unique relationship between neurologic and neruopsycholo-
gical measures in the HIV-positive group might be a function of the
effects of anxiety or depression. To evaluate this possibility, partial
correlations were calculated to investigate the relationship of neuro¬
logic and neuropsychological findings independent ofthe contribution
of depression and anxiety. Results were comparable with those de¬
scribed above: controlling for depression, anxiety, or both, there
were no significant correlations between neurologic and neuropsy¬
chological summary variables in the HIV-negative group. In con¬
trast, the relationships between neurologic and neuropsychological
summary measures remained significant in the HIV-positive group.
The neurologist's assessment of intellectual function is reflected in
the neurologic summary variables, so we considered the possibility
that the correlations between neurologic and neuropsychological
variables might reflect some redundancy in the measures. To address
this possibility, the cognitive component was eliminated from the
neurologic summary variables, and correlation coefficients with
neuropsychological variables were recalculated. A similar pattern
and magnitude of correlations were found, indicating that the rela¬
tionship is not a function of redundant assessment of intellectual
capacity.
Relationship of Symptoms to Neurologic Signs
and Neuropsychological Test Performance
In the symptom interview section of the neurologic evaluation,
HIV-positive men reported memory difficulty, depressed mood, and
loss of interest in socializing more often than did their HIV-negative
counterparts. When summary indexes were calculated for cognitive





Concentration/speed of thought 15.5 25.8 NS
Reading/television 7.1 15.3 NS
Memory 11.9 25.0 .03
Speech 9.5 14.5 NS
Cognitive index 22.6 38.7 .02
Motor/coordination symptoms
Gait 2.4 7.3 NS
Dexterity 1.2 8.8 NS
Involuntary movements 6.3 5.8 NS
Bladder incontinence 1.3 5.0 NS
Motor index 8.3 17.7 NS
Behavior/mood symptoms
Mood 17.8 35.5 .009
Apathy/withdrawal 8.3 26.6 .002
Emotional lability 13.1 20.2 NS
Behavior index 26.2 46.8 .004
Overall index 38.6 59.7 .005
*HIV indicates human immunodeficiency virus; NS; not significant.
tBy
 2 analysis.
and affective complaints, HIV-positive men had one or more subjec¬
tive complaints more often than did HIV-negative men (Table 7).
We compared men with and without specific cognitive complaints
to see if their symptoms were reflected in their neuropsychological
performance as measured by GPR or the clinical impression. Two-
way analyses of variance using HIV status (positive or negative) and
symptom complaint (present or absent) were calculated, with GPR
and clinical impression as the dependent variables. There were no
significant main or interaction effects when clinical impression was
the dependent variable. For GPR, the main effect of symptom com¬
plaint was significant, suggesting that, overall, complaints were
associated with poorer performance. The main effect for HIV status
was not present, confirming the observation of no significant differ¬
ence in GPR between HIV-negative and HIV-positive men. There
was no significant interaction between the two main effects, which
suggests that the relationship between symptom complaint and actu¬
al performance was similar in the HIV-positive and HIV-negative
groups.
In the HIV-positive group there was excellent agreement of sub¬jects' self-reported problems, including speed of thought, reading/
watching television, and memory, with neuropsychological perfor¬
mance as measured either by summary scores or by performance on
tests that assess function in the area of the complaint. In contrast,
there was no significant association between self-report of these
cognitive complaints and the actual neuropsychological performance
in the HIV-negative group.
COMMENT
Although comparison of the HIV-negative and HIV-positive
men revealed no difference in the frequency of defective or
borderline performance in any cognitive area and no difference
in the frequency of neurologic signs or severity of neurologic
dysfunction, other analyses suggest that there are significant
differences between the HIV-negative and HIV-positive men in
both neurologic and neuropsychological functions. First, HIV-
positive men performed slightly but significantly worse on sev¬
eral neuropsychological tests. Second, neuropsychological and
neurologic changes were interrelated in the HIV-positive but
not the HIV-negative men, suggesting that they may have a
common cause. Third, CD4/CD8 ratios correlated with neuro¬
logic and neuropsychological summary variables in the HIV-
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positive men only. Finally, symptomatic complaints in the HIV-
positive, but not the HIV-negative, men correlated with
objective measures of performance. These findings are dis¬
cussed in more detail below.
More HIV-positive men had borderline performance in at
least two cognitive areas, and the HIV-positive men performed
significantly worse on tests of memory, executive function,
attention, and abstract reasoning. These differences, although
statistically significant, actually represented only small raw
score differences and have no apparent clinical meaning. How¬
ever, they are striking because they remain detectable even
when only HIV-positive men who are completely medically
asymptomatic are considered. Also, they do not appear to be a
function of other possible variables, such as learning disability,
psychiatric status or history, alcohol or other drug abuse, or
language. It would be reasonable to hypothesize that the subtle
neuropsychological findings noted here represent one of the
earliest HIV-related changes detectable.
Because the changes are subtle, their interpretation is
problematic. Other groups, using similar tests and population
groups of comparable or even larger sizes, have not reported
differences. For example, the Air Force studies11 found no
difference between HIV-negative and HIV-positive medical¬
ly asymptomatic men on a battery of neuropsychological
tests. However, this study suffered from an inadequate con¬
trol group: servicemen who had sustained some head injury.
The potential contributions of head injury to neuropsycholo¬gical performance and the possible lack of comparability of
life-styles of subjects and controls are potential confounds.
The Multicenter AIDS Cohort Study groups" also found no
differences between asymptomatic seropositive and serone¬
gative individuals on a brief battery of neuropsychological
tests or on a larger battery administered to a selected subset
of patients either at baseline or on follow-up at 1 year.31Janssen et al12 also reported no difference in neuropsychologi¬
cal performance in HIV-negative and asymptomatic HIV-
positive men. In their article, comparison of individual scores
was restricted to a short screening battery. The results of the
full battery were presented only in terms of the frequency of
defective scores, which, as we report here, did not differ in
the two groups.
The disparity between these previous negative reports and
the subtle findings we now report could in some cases be afunction of the specific tests used. For example, the present
study as well as that of Wilkie et al8 used a selective reminding
procedure to assess verbal list learning, while the Multicenter
AIDS Cohort Study and Centers for Disease Control groups
used tests that did not, such as the Rey Auditory Verbal
Learning lest. The difference between the two procedures is
subtle: in the selective reminding procedure, the subject is
reminded only of the words he did not recall on his most recent
attempt, while in the Rey test the subject is supplied with the
entire list after each recall attempt. However, the selective
reminding procedure clearly places additional demands on the
subject that may entail set switching (ie, switching between
short- and long-term memory stores) or organizational or atten-
tional capacities. Along with potential differences between
neuropsychological tests ostensibly assessing the same cogni¬
tive function, many factors can contribute to different findings
across studies. These particularly include variations in subject
recruitment techniques or in time from serocon-version.
Despite these caveats, our data lend support to findings of
others, such as Grant et al,6 Wilkie et al,8 and Claypoole et al,38
which were similar to those described here. Whether these
subtle neuropsychological changes are predictive of later
medical or cognitive change remains to be determined.
Although a great deal ofeffort has been focused on describing
the neuropsychological changes seen in asymptomatic HIV-
positive individuals, little information is available on the preva¬
lence or incidence of neurologic signs, and standardized neuro¬
logic examinations have rarely been used. The relationship
between the presence of neurologic signs and neuropsychologi¬
cal or immunologie measures has also not been described.
The vast majority of neurologic symptoms and signs in
HIV-positive patients occur at a time when other systemic
complaints abound and the immunologie status of the patient
has declined. In the early stages of HIV infection, the mecha¬
nism of disease may be an autoimmune process dependent on
an intact immune system. Later, when the immune status is
further depressed, the mechanism may be the direct effect of
the virus.
Neurologic signs that may or may not be clinically signifi¬
cant are often present in asymptomatic HIV-positive individ¬
uals, but frequencies do not differ from those in seronegative
controls. In a study ofdrug users, 76% of the seronegative and
81% of the seropositive subjects had one or more neurologic
findings.39 Larger studies, including the Multicenter AIDS
Cohort Study2,4 and the Air Force,11 also found no significant
differences in medically asymptomatic homosexual men on
the basis of the neurologic examination.
The present study also did not find differences in the fre¬
quencies ofneurologic findings in the HIV-negative and HIV-
positive groups. Neurologic summary scores did relate to
indexes of depression and anxiety in both seropositive and
seronegative men. The subtle neurologic findings observed in
the HIV-negative and HIV-positive men might then be inter¬
preted as being related to the subjects' emotional state. It
should be noted that the great majority of neurologic signs
were of indeterminate clinical significance. In addition, it is
possible that many of these signs are state dependent and will
not be present at follow-up assessment. Despite these obser¬
vations, our data may suggest that there is a constellation of
subtle neurologic and neuropsychological signs associated
with early HIV infection. There was an inverse correlation
between the presence ofneurologic signs and CD4/CD8 ratios
in the HIV-positive men. In addition, there was a relationshipbetween the neurologic findings and the neuropsychological
variables that was unique to the HIV-positive men. Both of
these findings might suggest a common underlying factor for
these manifestations in the HIV-positive men: the viral effect
on the central (and perhaps simultaneously the peripheral)
nervous system could produce both neurologic and neuropsy-
chologic manifestations, resulting in significant correlations
between them. In contrast, neurologic signs in the HIV-
negative men did not covary with neuropsychological perfor¬
mance and may be more related to the other factors, such as
age, depression, and anxiety.
Self-reports of cognitive symptoms are subject to myriad
influences, including mood, medical status, and concern relat¬
ed to disease state. The ability to detect a relationship be¬
tween self-perceived and actual abilities may be highly depen¬
dent on the instruments used both to elicit symptoms and to
assess cognitive function.
The present data suggest that HIV-positive men experi¬
ence more cognitive symptoms than do their HIV-negative
counterparts. Further, these symptoms have validity: sub¬jective complaints are associated with poorer performance as
assessed by neuropsychological summary scores and by spe¬
cific assessments of the area of self-reported complaint. Some
of our data using specific test scores as opposed to summary
measures suggest that the complaints of the seropositive men
were better related to the neuropsychological indexes. It is
possible that the range and severity of self-complaints in the
HIV-negative group were lower, making it more difficult to
relate them to other variables.
There was little evidence of a relationship between HIV
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severity and neurologic or neuropsychological symptoms. In
the the HIV-positive men, neurologic and some neuropsycho¬
logical summary variables correlated with CD4/CD8 ratios,
suggesting poorer function as this ratio is diminished. How¬
ever, medically asymptomatic men, the majority ofwhom had
CD4 counts above 0.4  10YL, had the same pattern ofperfor¬
mance relative to the HIV-negative men that was seen in the
HIV-positive group as a whole. The HIV-positive men in this
cohort were specifically selected to be relatively asymptomat¬
ic to allow us to describe the early natural course of HIV
infection; accurate analysis of relationships between the
range of HIV infection and neurologic or neuropsychological
changes awaits follow-up data.
The interpretation of the present results is complicated by
the subject recruitment techniques employed. These are de¬
scribed in more detail in an accompanying article13; in general,
volunteers were recruited with newspaper advertisements or
by word ofmouth. It is possible that this could produce a bias
toward individuals who were concerned about the possible
presence of HIV-related symptoms. Alternately, men with
more severe symptoms may not have wished to or been
capable of volunteering. In addition, the men's knowledge of
their serologie status might have influenced their perfor¬
mance and self-reports in some fashion. Although these con¬
cerns are applicable to many ofthe studies in this area, they do
limit the generalizability of the present findings beyond this
particular cohort ofmen.
The present data suggest that subtle neuropsychological
changes, associated with subtle neurologic signs and subjec¬
tive complaints, can be found in the medically asymptomatic
HIV-positive patient. This constellation may reflect a syn¬
drome that will be recognized as one of the early manifesta¬
tions of the direct effect of HIV on the nervous system.
Although these changes are not sufficient to impact on a
person's day-to-day functioning, they may be predictive of
later cognitive changes or of disease progression.
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